Clinical trial
Natural History Study of Adult Patients With Paroxysmal Nocturnal Hemoglobinuria of High-risk Hemolysis in China
NCT05125341 is registered in ClinicalTrials.gov with CARE Pharma Shanghai Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Natural History Study of Adult Patients With Paroxysmal Nocturnal Hemoglobinuria of High-risk Hemolysis in China
- Lead sponsor
- CARE Pharma Shanghai Ltd.
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 25, 2021
- Completion date
- April 30, 2022
- Enrollment
- 67 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
paroxysmal nocturnal hemoglobinuria, natural history study